Regulated information

Monthly information regarding the total number of voting rights and shares making of the share capital - November2011

As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers »

Monthly information regarding the total number of voting rights and shares making of the share capital - October 2011

As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers »

Q3 2011 Sales

Vétoquinol achieved Q3 2011 sales of €68.4 million, in line with the previous year.

Jacques du Puy appointed Vétoquinol Managing Director

Lure (France), October 12, 2011 – The Vétoquinol Group announces the appointment
of Jacques du Puy as Managing Director.

Monthly information regarding the total number of voting rights and shares making of the share capital - September 2011

As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers »

Forcyl®: european launch of new drug

Lure (France), September 29, 2011 – Vétoquinol announces the European launch of Forcyl®, a new drug based on 16% concentrated marbofloxacin allowing the treatment of cattle respiratory infections with a single injection.

Monthly information regarding the total number of voting rights and shares making of the share capital - August 2011

As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers »

Monthly information regarding the total number of voting rights and shares making of the share capital - July 2011

As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers »

Rapport financier semestriel 2011 (french)

> Rapport d’activité semestriel 2011
<br>> Etats financiers consolidés résumés au 30 juin 2011
<br>> Attestation du responsable du document
<br>> Rapport des commissaires aux comptes sur l&rsquo;information financière semestrielle 2011

2011 Half Year Results

2011 Half year results